Wang Jinping, Zhang Beilu, Sun Jingyu, Hu Wei, Wang Hongjun
Department of Biomedical Engineering, Stevens Institute of Technology, Hoboken, New Jersey, 07030, United States.
Key Laboratory of Molecular Biophysics of Hebei Province, Institute of Biophysics, School of Sciences, Hebei University of Technology, 300401, Tianjin, PR China.
Nano Today. 2021 Jun;38. doi: 10.1016/j.nantod.2021.101146. Epub 2021 Apr 8.
Porous nanomaterials with high surface area, tunable porosity, and large mesopores have recently received particular attention in cancer therapy and imaging. Introduction of additional pores to nanostructures not only endows the tunability of optoelectronic and optical features optimal for tumor treatment, but also modulates the loading capacity and controlled release of therapeutic agents. In recognition, increasing efforts have been made to fabricate various porous nanomaterials and explore their potentials in oncology applications. Thus, a systematic and comprehensive summary is necessary to overview the recent progress, especially in last ten years, on the development of various mesoporous nanomaterials for cancer treatment as theranostic agents. While outlining their individual synthetic mechanisms after a brief introduction of the structures and properties of porous nanomaterials, the current review highlighted the representative applications of three main categories of porous nanostructures (organic, inorganic, and organic-inorganic nanomaterials). In each category, the synthesis, representative examples, and interactions with tumors were further detailed. The review was concluded with deliberations on the key challenges and future outlooks of porous nanostructures in cancer theranostics.
具有高比表面积、可调孔隙率和大孔径的多孔纳米材料最近在癌症治疗和成像方面受到了特别关注。在纳米结构中引入额外的孔隙不仅赋予了对肿瘤治疗最优的光电和光学特性的可调性,还调节了治疗剂的负载能力和控释。认识到这一点后,人们越来越努力地制备各种多孔纳米材料,并探索它们在肿瘤学应用中的潜力。因此,有必要进行系统而全面的总结,以概述各种用于癌症治疗的介孔纳米材料作为诊疗剂的最新进展,特别是过去十年的进展。在简要介绍多孔纳米材料的结构和性质后,本综述在概述其各自的合成机制时,重点介绍了三类主要多孔纳米结构(有机、无机和有机 - 无机纳米材料)的代表性应用。在每一类中,进一步详细阐述了合成方法、代表性实例以及与肿瘤的相互作用。综述最后对多孔纳米结构在癌症诊疗中的关键挑战和未来展望进行了讨论。